Neonatology

Research Briefings

The ‘Effects of Transfusion Thresholds on Neurocognitive Outcome of Extremely Low Birth-Weight Infants (ETTNO)’ Study: Background, Aims, and Study Protocol

Author affiliations

aDepartment of Neonatology, University Children’s Hospital, Vienna, Austria; Departments of bNeonatology, and cAnaesthesia and Pain Management, The Royal Children’s Hospital, Parkville, Vic., dMurdoch Children’s Research Institute, and eClinical Epidemiology and Biostatistics Unit, Murdoch Children’s Research Institute, and fDepartment of Paediatrics, The University of Melbourne, Melbourne, Vic., Australia

Related Articles for ""

Neonatology 2012;101:301–305

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Research Briefings

Received: September 27, 2011
Accepted: November 10, 2011
Published online: January 27, 2012
Issue release date: June 2012

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 1

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

Background: Infants with extremely low birth weight uniformly develop anemia of prematurity and frequently require red blood cell transfusions (RBCTs). Although RBCT is widely practiced, the indications remain controversial in the absence of conclusive data on the long-term effects of RBCT. Objectives: To summarize the current equipoise and to outline the study protocol of the ‘Effects of Transfusion Thresholds on Neurocognitive Outcome of extremely low birth-weight infants (ETTNO)’ study. Methods: Review of the literature and design of a large pragmatic randomized controlled trial of restrictive versus liberal RBCT guidelines enrolling 920 infants with birth weights of 400–999 g with long-term neurodevelopmental follow-up. Results and Conclusions: The results of ETTNO will provide definite data about the efficacy and safety of restrictive versus liberal RBCT guidelines in very preterm infants.

© 2012 S. Karger AG, Basel




Related Articles:


References

  1. Bifano EM, Curran TR: Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 1995;22:657–669.
  2. Widness JA, Seward VJ, Kromer IJ, Burmeister LF, Bell EF, Strauss RG: Changing patterns of red blood cell transfusion in very low birth weight infants. J Pediatr 1996;129:680–687.
  3. Asch J, Wedgwood JF: Optimizing the approach to anemia in the preterm infant: is there a role for erythropoietin therapy? J Perinatol 1997;17:276–282.
  4. Bassler D, Weitz M, Bialkowski A, Poets CF: Restrictive versus liberal red blood cell transfusion strategies for preterm infants: a systematic review of randomized controlled trials. Curr Pediatr Rev 2008;4:143–150.
    External Resources
  5. Crowley M, Kirpalani H: A rational approach to red blood cell transfusion in the neonatal ICU. Curr Opin Pediatr 2010;22:151–157.
  6. Linderkamp O, Zilow EP, Zilow G: The critical hemoglobin value in newborn infants, infants and children (in German). Beitr Infusionsther 1992;30:235–246.
  7. Blanchette VS, Hume HA, Levy GJ, Luban NL, Strauss RG: Guidelines for auditing pediatric blood transfusion practices. Am J Dis Child 1991;145:787–796.
  8. Maier RF, Metze B, Obladen M: Low degree of regionalization and high transfusion rates in very low birthweight infants: a survey in Germany. J Perinat Med 1998;26:43–48.
  9. Bednarek FJ, Weisberger S, Richardson DK, Frantz IDr, Shah B, Rubin LP: Variations in blood transfusions among newborn intensive care units. SNAP II Study Group. J Pediatr 1998;133:601–607.
  10. Ringer SA, Richardson DK, Sacher RA, Keszler M, Churchill WH: Variations in transfusion practice in neonatal intensive care. Pediatrics 1998;101:194–200.
  11. Cooke RW, Clark D, Hickey-Dwyer M, Weindling AM: The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 1993;152:833–836.
  12. Hesse L, Eberl W, Schlaud M, Poets CF: Blood transfusion. Iron load and retinopathy of prematurity. Eur J Pediatr 1997;156:465–470.
  13. Inder TE, Clemett RS, Austin NC, Graham P, Darlow BA: High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997;131:541–544.
  14. Cooke RW, Drury JA, Yoxall CW, James C: Blood transfusion and chronic lung disease in preterm infants. Eur J Pediatr 1997;156:47–50.
  15. Silvers KM, Gibson AT, Russell JM, Powers HJ: Antioxidant activity, packed cell transfusions, and outcome in premature infants. Arch Dis Child Fetal Neonatal Ed 1998;78:F214– F219.
  16. Joshi VH, Joshi PV, Webert K, Cairnie J, Sabourin T, Blajchman M, Kirpalani H: Does transfusion related acute lung injury (TRALI) occur in newborns? PAS-Abstr 2006;59:460.
  17. Paul DA, Mackley A, Novitsky A, Zhao Y, Brooks A, Locke RG: Increased odds of necrotizing enterocolitis after transfusion of red blood cells in premature infants. Pediatrics 2011;127:635–641.
  18. Blau J, Calo JM, Dozor D, Sutton M, Alpan G, La Gamma EF: Transfusion-related acute gut injury: necrotizing enterocolitis in very low birth weight neonates after packed red blood cell transfusion. J Pediatr 2011;158:403–409.
  19. Christensen RD, Lambert DK, Henry E, Wiedmeier SE, Snow GL, Baer VL, Gerday E, Ilstrup S, Pysher TJ: Is ‘transfusion-associated necrotizing enterocolitis’ an authentic pathogenic entity? Transfusion 2010;50:1106–1112.
  20. Baer VL, Lambert DK, Henry E, Snow GL, Butler A, Christensen RD: Among very-low-birth-weight neonates is red blood cell transfusion an independent risk factor for subsequently developing a severe intraventricular hemorrhage? Transfusion 2011;51:1170–1178.
  21. dos Santos AM, Guinsburg R, de Almeida MF, Procianoy RS, Leone CR, Marba ST, Rugolo LM, Fiori HH, Lopes JM, Martinez FE: Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants. J Pediatr 2011;159:371–376 e1–3.
  22. Kirpalani H, Whyte R: Truths, associations, and hypotheses. J Pediatr 2011;159:359–361.
  23. Busch MP, Kleinman SH, Nemo GJ: Current and emerging infectious risks of blood transfusions. JAMA 2003;289:959–962.
  24. Alagappan A, Shattuck KE, Malloy MH: Impact of transfusion guidelines on neonatal transfusions. J Perinatol 1998;18:92–97.
  25. Baer VL, Henry E, Lambert DK, Stoddard RA, Wiedmeier SE, Eggert LD, Ilstrup S, Christensen RD: Implementing a program to improve compliance with neonatal intensive care unit transfusion guidelines was accompanied by a reduction in transfusion rate: a pre-post analysis within a multihospital health care system. Transfusion 2010;51:264–269.
  26. Franz AR, Pohlandt F: Red blood cell transfusions in very and extremely low birth weight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed 2001;84:F96–F100.
  27. Strauss RG: Commentary: is it safe to limit allogeneic red blood cell transfusions to neonates? Neonatology 2008;93:217–222.
  28. Bell EF, Strauss RG, Widness JA, Mahoney LT, Mock DM, Seward VJ, Cress GA, Johnson KJ, Kromer IJ, Zimmerman MB: Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005;115:1685–1691.
  29. Boedy RF, Mathew OP: Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics 2005;116:1048–1049.
  30. Murray N, Roberts I, Stanworth S: Red blood cell transfusion in neonates. Pediatrics 2005;116:1609.
  31. Swamy RS, Embleton ND: Red blood cell transfusions in preterm infants: is there a difference between restrictive and liberal criteria? Pediatrics 2006;117:257–258.
  32. McCoy TE, Conrad AL, Richman LC, Lindgren SD, Nopoulos PC, Bell EF: Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol 2011:1–21.
  33. Nopoulos PC, Conrad AL, Bell EF, Strauss RG, Widness JA, Magnotta VA, Zimmerman MB, Georgieff MK, Lindgren SD, Richman LC: Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions. Arch Pediatr Adolesc Med 2010;165:443–450.
    External Resources
  34. Kirpalani H, Whyte RK, Andersen C, Asztalos EV, Heddle N, Blajchman MA, Peliowski A, Rios A, LaCorte M, Connelly R, Barrington K, Roberts RS: The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr 2006;149:301–307.
  35. Whyte RK, Kirpalani H, Asztalos EV, Andersen C, Blajchman M, Heddle N, LaCorte M, Robertson CM, Clarke MC, Vincer MJ, Doyle LW, Roberts RS: Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 2009;123:207–213.
  36. Kamholz KL, Dukhovny D, Kirpalani H, Whyte RK, Roberts RS, Wang N, Mao W, Zupancic JA: Economic evaluation alongside the Premature Infants in Need of Transfusion randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2011; epub ahead of print.
  37. Bell EF: Transfusion thresholds for preterm infants: how low should we go? J Pediatr 2006;149:287–289.
  38. Böhler T, Janecke A, Linderkamp O: Blood transfusion in late anemia of prematurity: effect on oxygen consumption, heart rate, and weight gain in otherwise healthy infants. Infusionsther Transfusionsmed 1994;21:376–379.
  39. Maier RF, Sonntag J, Walka MM, Liu G, Metze BC, Obladen M: Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g. J Pediatr 2000;136:220–224.
  40. Murray NA, Roberts IA: Neonatal transfusion practice. Arch Dis Child Fetal Neonatal Ed 2004;89:F101– F107.
  41. Bell EF: When to transfuse preterm babies. Arch Dis Child Fetal Neonatal Ed 2008;93:F469– F473.

Article / Publication Details

First-Page Preview
Abstract of Research Briefings

Received: September 27, 2011
Accepted: November 10, 2011
Published online: January 27, 2012
Issue release date: June 2012

Number of Print Pages: 5
Number of Figures: 0
Number of Tables: 1

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP